← Leaderboards
Ioannis Vlachos
Beth Israel Deaconess Medical Center
$3,942,666
Attributed
$4,996,683
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$10,776,120 · 4
By mechanism
U54$5,779,437 · 1
R01$4,466,137 · 2
P01$530,546 · 1
Top collaborators
- Young-Kwon Hong5 shared
- Dhruv Singhal5 shared
- Vassiliki A Boussiotis3 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- John V Frangioni$42,386,239
- Dhruv Singhal$3,438,750
- Jerome E Groopman$14,405,534
- Vassiliki A Boussiotis$19,288,605
- Leo Lee Tsai$2,385,455
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectResourcesSamplingResearch PersonnelTranscriptomicsCellsImmuneMolecular3-DimensionalTranscriptomeMalignant NeoplasmsDetectionInfrastructureData IntegrationImmunotherapyMediatingProceduresCommunitiesCancer ImmunotherapyProgramsCancer PatientHuman ResourcesImmune SystemGenerations
Grant awards (14)
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,329,999
U54 · FY2025 · HL
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy$709,419
R01 · FY2025 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion$588,394
R01 · FY2025 · CA · contact PI
Core C- BIDMC Core$227,481
P01 · FY2025 · AI · contact PI
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,749,517
U54 · FY2024 · HL
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy$675,994
R01 · FY2024 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion$540,818
R01 · FY2024 · CA · contact PI
Core C- BIDMC Core$303,065
P01 · FY2024 · AI · contact PI
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,250,000
U54 · FY2023 · HL
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy$722,621
R01 · FY2023 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion$610,423
R01 · FY2023 · CA · contact PI
Multi-scale Spatial Mapping of Human Lymphatic Vessels$199,921
U54 · FY2023 · HL
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,250,000
U54 · FY2022 · HL
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion$618,468
R01 · FY2022 · CA · contact PI